# The Study of Safety and Preliminary Efficacy of ALT001 in Patients With MultIple System Atrophy-Cerebellar Type

> **NCT07514923** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **yilong Wang** · enrollment: 20 (estimated)

## Conditions studied

- Multiple System Atrophy - Cerebellar Subtype (MSA-C)

## Interventions

- **DRUG:** ALT001

## Key facts

- **NCT ID:** NCT07514923
- **Lead sponsor:** yilong Wang
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-06
- **Primary completion:** 2027-01-31
- **Final completion:** 2027-10-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07514923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07514923, "The Study of Safety and Preliminary Efficacy of ALT001 in Patients With MultIple System Atrophy-Cerebellar Type". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07514923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*